DE69907161D1 - 5' deoxycytidin-derivative - Google Patents

5' deoxycytidin-derivative

Info

Publication number
DE69907161D1
DE69907161D1 DE69907161T DE69907161T DE69907161D1 DE 69907161 D1 DE69907161 D1 DE 69907161D1 DE 69907161 T DE69907161 T DE 69907161T DE 69907161 T DE69907161 T DE 69907161T DE 69907161 D1 DE69907161 D1 DE 69907161D1
Authority
DE
Germany
Prior art keywords
deoxycytidine derivatives
deoxycytidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69907161T
Other languages
English (en)
Other versions
DE69907161T2 (de
Inventor
Kazuo Hattori
Tohru Ishikawa
Hideo Ishitsuka
Yasunori Kohchi
Nobuhiro Oikawa
Nobuo Shimma
Hitomi Suda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE69907161D1 publication Critical patent/DE69907161D1/de
Publication of DE69907161T2 publication Critical patent/DE69907161T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/167Purine radicals with ribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69907161T 1998-02-06 1999-02-03 5' deoxycytidin-derivative Expired - Fee Related DE69907161T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP98102080 1998-02-06
EP98102080 1998-02-06
EP98108321 1998-05-07
EP98108321 1998-05-07
PCT/EP1999/000710 WO1999040099A1 (en) 1998-02-06 1999-02-03 5'-deoxycytidine derivatives

Publications (2)

Publication Number Publication Date
DE69907161D1 true DE69907161D1 (de) 2003-05-28
DE69907161T2 DE69907161T2 (de) 2004-02-05

Family

ID=26149007

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69907161T Expired - Fee Related DE69907161T2 (de) 1998-02-06 1999-02-03 5' deoxycytidin-derivative

Country Status (19)

Country Link
US (1) US6005098A (de)
EP (1) EP1060183B1 (de)
JP (2) JP3625276B2 (de)
KR (1) KR100381516B1 (de)
CN (1) CN1260240C (de)
AR (1) AR014539A1 (de)
AT (1) ATE238335T1 (de)
AU (1) AU757136B2 (de)
BR (1) BR9907672A (de)
CA (1) CA2318848C (de)
CO (1) CO5070642A1 (de)
DE (1) DE69907161T2 (de)
DK (1) DK1060183T3 (de)
ES (1) ES2195543T3 (de)
MA (1) MA26606A1 (de)
PE (1) PE20000244A1 (de)
PT (1) PT1060183E (de)
TR (1) TR200002297T2 (de)
WO (1) WO1999040099A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119724A1 (en) * 1995-11-22 2003-06-26 Ts`O Paul O.P. Ligands to enhance cellular uptake of biomolecules
EP0882734B1 (de) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5-Deoxy-Cytidin-Derivate
DE60013957T2 (de) 1999-05-26 2006-02-23 F. Hoffmann-La Roche Ag Verfahren zur Herstellung von Vinylpyrimidinderivaten
KR100631754B1 (ko) * 2000-08-09 2006-10-09 주식회사 코오롱 N-알킬옥시카르보닐-5-플루오로사이토신 유도체 및 그의제조방법
AU2002217980A1 (en) 2000-12-01 2002-06-11 Cell Works Inc. Conjugates of glycosylated/galactosylated peptide
CN100383128C (zh) * 2004-02-23 2008-04-23 上海迪赛诺医药发展有限公司 N4-氧羰基胞嘧啶衍生物及制备方法与应用
DE112006000873T5 (de) * 2005-04-12 2008-03-06 Elan Pharma International Ltd. Zusammensetzungen mit modifizierter Freisetzung, umfassend ein Fluorcytidin-Derivate zur Behandlung von Krebs
JP6866113B2 (ja) * 2016-11-01 2021-04-28 日本化薬株式会社 カペシタビンを有効成分とする医薬製剤
JP6792418B2 (ja) * 2016-11-08 2020-11-25 日本化薬株式会社 カペシタビンを有効成分とする医薬製剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561290A (en) * 1975-10-16 1980-02-20 Nyegaard & Co As Pyrimid - 2 - ones
JPS54129131A (en) * 1978-03-27 1979-10-06 Taiho Pharmaceutical Co Ltd Antiimalignant tumor agent composition
GB2016921B (en) * 1978-03-27 1982-08-18 Taiho Pharmaceutical Co Ltd Anti cancer compositions containing uracil derivatives
US4328229A (en) * 1978-03-29 1982-05-04 Taiho Pharmaceutical Company Limited Anti-cancer composition for delivering 5-fluorouracil to cancer tissues
CA1327358C (en) * 1987-11-17 1994-03-01 Morio Fujiu Fluoro cytidine derivatives
DK0539442T3 (da) * 1990-07-19 1998-09-07 Wellcome Found Enzyminaktivatorer
GB9020930D0 (en) * 1990-09-26 1990-11-07 Wellcome Found Pharmaceutical combinations
EP0543015B1 (de) * 1991-05-27 1998-11-11 Taiho Pharmaceutical Co., Ltd. Zusammensetzung, verfahren und instrument zur potenzierung der antitumoraktivität und zur behandlung von tumoren
AU671491B2 (en) * 1992-12-18 1996-08-29 F. Hoffmann-La Roche Ag N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines
TW254946B (de) * 1992-12-18 1995-08-21 Hoffmann La Roche
EP0882734B1 (de) * 1997-06-02 2009-08-26 F. Hoffmann-La Roche Ag 5-Deoxy-Cytidin-Derivate

Also Published As

Publication number Publication date
CA2318848A1 (en) 1999-08-12
DE69907161T2 (de) 2004-02-05
AR014539A1 (es) 2001-02-28
JP2004339230A (ja) 2004-12-02
JP2002502857A (ja) 2002-01-29
CA2318848C (en) 2008-09-02
MA26606A1 (fr) 2004-12-20
KR100381516B1 (ko) 2003-04-23
US6005098A (en) 1999-12-21
EP1060183B1 (de) 2003-04-23
AU2722799A (en) 1999-08-23
CN1290269A (zh) 2001-04-04
WO1999040099A1 (en) 1999-08-12
DK1060183T3 (da) 2003-08-11
KR20010072543A (ko) 2001-07-31
EP1060183A1 (de) 2000-12-20
CO5070642A1 (es) 2001-08-28
ATE238335T1 (de) 2003-05-15
PT1060183E (pt) 2003-08-29
CN1260240C (zh) 2006-06-21
ES2195543T3 (es) 2003-12-01
TR200002297T2 (tr) 2000-12-21
JP3625276B2 (ja) 2005-03-02
PE20000244A1 (es) 2000-04-10
BR9907672A (pt) 2000-11-28
AU757136B2 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
NO20010193L (no) Tiobenzimidazol-derivater
DK0930302T3 (da) Benzosulfonderivater
ATE259810T1 (de) Phenyl-xanthinderivate
NO20010514D0 (no) Aminometylkarboksylsyre-derivater
DK1000048T3 (da) Substituerede 1,2,3,4-tetrahydronapthalenderivater
PT1090019E (pt) Derivados de adenosina
PT928790E (pt) Derivados de tiazolo
ATE257484T1 (de) 6,9-verbrückte erythromycin-derivate
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
DK1140835T3 (da) 3,3-biarylpiperidin- og 2,2-biarylmorpholon-derivater
TR199800988A3 (tr) 5' Deoksi-Sitidin türevleri.
EE200000447A (et) 1,3,4-oksadiasolooni derivaadid
PT1056716E (pt) Derivados de ciclo-hexanodiolo
DK1115716T3 (da) 2-phenylpyran-4-on-derivater
ATE233253T1 (de) Chromanderivate
DK1134219T3 (da) Cucloalkylsubstituerede aminomethylpyrrolidinderivater
DE69907161D1 (de) 5' deoxycytidin-derivative
PT1123283E (pt) Derivados de tiazole
ATE243218T1 (de) 2''-deoxyhygromycinderivate
DE59907635D1 (de) Pyrazolyldioxothiochromanoyl-derivate
PT928793E (pt) Derivados de tiazol
MA26481A1 (fr) Derives d'arylsecocholadiene
FI980765A0 (fi) Tillrinningsvask "skyddssystem"

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee